Use of novel adjuvants and delivery systems to improve the humoral and cellular immune response to malaria vaccine candidate antigens

This publication has 10 references indexed in Scilit:

• Safety, immunogenicity, and efficacy of a Plasmodium falciparum vaccine comprising a circumsporozoite protein repeat region peptide conjugated to Pseudomonas aeruginosa toxin A
  Infection and Immunity, 1992
• Phagocytosis of liposomes by macrophages: intracellular fate of liposomal malaria antigen
  Biochimica et Biophysica Acta (BBA) - Biomembranes, 1991
• Liposomes as carriers of antigens and adjuvants
  Journal of Immunological Methods, 1991
• Use of adjuvant containing mycobacterial cell-wall skeleton, monophosphoryl lipid A, and squalane in malaria circumsporozoite protein vaccine
  The Lancet, 1991
• Malaria Vaccines
  Infectious Disease Clinics of North America, 1990
• Immunogenicity of liposomal malaria sporozoite antigen in monkeys: adjuvant effects of aluminium hydroxide and non-pyrogenic liposomal lipid A
  Vaccine, 1989
• Cloned cytotoxic T cells recognize an epitope in the circumsporozoite protein and protect against malaria
  Nature, 1989
• Specificities of antibodies that inhibit merozoite dispersal from malaria-infected erythrocytes
  Molecular and Biochemical Parasitology, 1989
• SAFETY AND EFFICACY OF A RECOMBINANT DNA PLASMODIUM FALCIPARUM SPOROZOITE VACCINE
  The Lancet, 1987
• Phase-I study of intravenous modified lipid A
  Cancer Immunology, Immunotherapy, 1984